tiprankstipranks
Cipher Pharmaceuticals (CPHRF)
OTHER OTC:CPHRF
US Market
CPHRF
Cipher Pharmaceuticals
RESEARCH TOOLSreports
Want to see CPHRF full AI Analyst Report?

Cipher Pharmaceuticals (CPHRF) Income Statement

20 Followers

Cipher Pharmaceuticals Income Statement

Last quarter (Q4 2025), Cipher Pharmaceuticals's total revenue was $12.41M, an increase of 4.94% from the same quarter last year. In Q4, Cipher Pharmaceuticals's net income was $13.52M. See Cipher Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 51.33M$ 33.36M$ 21.16M$ 20.68M$ 21.94M
Gross Profit
$ 33.77M$ 24.10M$ 17.09M$ 16.68M$ 18.26M
Operating Expenses
$ 16.97M$ 16.25M$ 5.56M$ 5.63M$ 6.45M
Depreciation and Amortization
$ 0.00$ 4.02M$ 1.23M$ 989.00K$ 701.00K
EBITDA
$ 16.80M$ 11.87M$ 11.53M$ 12.04M$ 13.66M
Operating Income
$ 16.80M$ 7.85M$ 11.53M$ 12.04M$ 11.82M
Other Income/Expenses
$ 661.38K$ -4.89M$ 1.15M$ -560.00K$ -2.00M
Pretax Income
$ 17.46M$ 2.96M$ 12.68M$ 11.48M$ 11.06M
Net Income
$ 27.81M$ 11.54M$ 20.38M$ 26.64M$ 7.76M
Per Share Metrics
Basic EPS
$ 1.09$ 0.46$ 0.80$ 1.06$ 0.29
Diluted EPS
$ 1.07$ 0.47$ 0.80$ 1.04$ 0.29
Weighted Average Shares Outstanding
 25.48M 24.72M 25.48M 25.13M 26.60M
Weighted Average Shares Outstanding (Diluted)
 25.99M 24.57M 25.42M 25.59M 26.83M
Currency in USD

Cipher Pharmaceuticals Earnings and Revenue History